Persenone A from Avocados Exhibits Potent Anti-Fungal Activity against Coccidioides

Vladimir Maslivetc1, Susana Tejeda-Garibay2, Adeola Fagbayibo2

  • 1Jack H. Skirball Center for Chemical Biology and Proteomics, The Salk Institute for Biological Studies, 10010 North Torrey Pines Rd., La Jolla, California92037, United States.

Insights

Valley fever (coccidioidomycosis) treatments are limited. Researchers screened California plants for compounds inhibiting Coccidioides growth, identifying persenone A from avocados as a promising new therapeutic lead.

Area of Science:

  • Mycology
  • Pharmacognosy
  • Infectious Diseases

Background:

  • Coccidioidomycosis, a fungal respiratory illness caused by Coccidioides species, presents a growing public health concern due to its expanding endemic range.
  • Current therapeutic options for Valley fever exhibit limited efficacy and notable adverse effects, necessitating the search for novel treatments.

Purpose of the Study:

  • To investigate the potential of California's diverse flora as a source for new agents targeting early-stage Coccidioides development.
  • To identify natural compounds that can inhibit the growth and proliferation of Coccidioides fungal species.

Main Methods:

  • Development of a screening protocol integrating a colorimetric metabolism assay and microscopic imaging for evaluating plant extracts.
  • Application of the established screening protocol to a library of plant extracts sourced from local flora in San Diego, California.

Main Results:

  • Discovery of persenone A, a potent inhibitor of Coccidioides development, isolated from avocado plant extracts.
  • Successful identification of a natural compound with significant antifungal activity against the causative agents of Valley fever.

Conclusions:

  • Avocado-derived persenone A represents a promising lead compound for developing new therapeutic strategies against Coccidioidomycosis.
  • Botanical resources, particularly from regions like California, offer a valuable avenue for discovering novel antifungal agents.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Introduction to Plant Diversity02:22

Introduction to Plant Diversity

From Water to Land
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...